home / stock / opti:cc / opti:cc news

OPTI:CC News and Press, Optimi Health Corp. From 11/28/23

Stock Information
Company Name: Optimi Health Corp.
Stock Symbol: OPTI:CC
Market: CNQC
Website: optimihealth.ca
Menu
OPTI:CC OPTI:CC Quote OPTI:CC Short OPTI:CC News OPTI:CC Articles OPTI:CC Message Board
Get OPTI:CC Alerts

News, Short Squeeze, Breakout and More Instantly...
OPTI:CC - Optimi Health Achieves Genetics Milestone and Completes Psilocybin Extract Validation and Stability Testing

VANCOUVER, British Columbia, Nov. 28, 2023 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN), a leading end-to-end drug researcher and formulator licensed by Health Canada, has reached a significant milestone in its mission. The company is proud to announce the success...
OPTI:CC - Optimi Health Resolves Dispute

VANCOUVER, British Columbia, Nov. 10, 2023 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) ("Optimi" or the "Company") is pleased to announce the successful resolution of a dispute that arose in connection with a termination notice related to a supply agreement ("the...

OPTI:CC - Optimi Health Welcomes Dr. Preston A. Chase as New Chief Science Officer

VANCOUVER, British Columbia, Nov. 07, 2023 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN), a leading Canadian psychedelics drug research and formulation company, is delighted to announce the appointment of Dr. Preston A. Chase as the Company’s Chief Science O...

OPTI:CC - Optimi Health Announces Third and Final Tranche of CAD $1,000,000 Secured for Debt Financing

VANCOUVER, British Columbia, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“ Optimi Health ” or the “ Company ”), a Canadian drug research and formulation company licensed by Health Canada to manufacture psychedeli...
OPTI:CC - Optimi Health Celebrates Encouraging Results from the MAPS Phase 3 MDMA-Assisted Therapy Clinical Trial

VANCOUVER, British Columbia, Sept. 14, 2023 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN), a Canadian psychedelics drug research and formulation company, is pleased to see the positive and encouraging outcomes from the MAPS Phase 3 MDMA-Assisted Therapy (MDMA-AT) C...

OPTI:CC - Optimi Health Granted Amendment to Dealer's Licence by Health Canada to Supply Special Access Program

VANCOUVER, British Columbia, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN), a Canadian psychedelics drug research and formulation company, proudly announced today that Health Canada has approved an amendment to the Company’s Dealer's Licence. ...

OPTI:CC - Optimi Health Announces Second Tranche of CAD $1,000,000 Secured for Debt Financing

VANCOUVER, British Columbia, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“ Optimi Health ” or the “ Company ”), a Canadian drug research and formulation company licensed by Health Canada to manufacture psychedel...
OPTI:CC - Optimi Health Announces CAD $3,000,000 Senior Debt Financing

VANCOUVER, British Columbia, Aug. 10, 2023 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN), a Canadian drug research and formulation company licensed by Health Canada to manufacture psychedelic substances such as MDMA and high-quality, GMP-grade natural psilocybin, i...

OPTI:CC - Optimi Completes Proprietary Natural Psilocybin Extraction Process and Files U.S. Provisional Patent

VANCOUVER, British Columbia, Aug. 01, 2023 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), an end-to-end drug researcher and formulator licensed by Health Canada to produce and supply, for clinical research pur...

OPTI:CC - Optimi Health Announces Receipt of Purported Termination Notice

VANCOUVER, British Columbia, July 27, 2023 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”) has received a termination notice and demand for payment pursuant to a definitive supply agreement (the “Supply A...
Previous 10 Next 10